Irritable bowel syndrome with constipation: issues of pathogenesis, diagnostics and treatment
Abstract
Issues related to the diagnosis and treatment of irritable bowel syndrome occupy one of the central places in gastroenterology, due to the fact that in recent years there has been a significant increase in the incidence of this syndrome, its long-term recurrent, often lifelong course, leading to a decrease in the performance of patients, despite good quality, and a significant cost to the health care system. Irritable bowel syndrome, despite its functional nature, occurs quite often - from 14-50% of the adult population according to population epidemiological studies, and the ratio of women to men is from 2: 1 to 4:1. In the structure of gastroenterological pathology, this disease accounts for 40-70% of all cases of seeking medical help. Irritable bowel syndrome is a complex of functional disorders of the distal intestines, lasting more than 3 months and accompanied by abdominal pain that disappears after a bowel movement, flatulence, a feeling of incomplete bowel movement, changes in the frequency and consistency of stools. Factors in the pathogenesis of irritable bowel syndrome are dysfunction of mental activity with changes in autonomic and humoral functions; visceral hypersensitivity and impaired intestinal motility, past intestinal infection; endocrine disorders; food allergies, sedentary lifestyle; genetic predisposition. Endothelial dysfunction has recently played an important role in the onset of irritable bowel syndrome. The most famous among the factors of vascular endothelium today are the powerful vasoconstrictor endothelin-1 and the vasodilator - nitric oxide. The study investigated the level of vasoconstrictor endothelin-1 and vasodilator of nitric oxide in patients with irritable bowel syndrome with constipation. It was found that such patients have severe endothelial dysfunction, which manifests itself in an increase in the level of endothelin-1 (р˂0,01), a decrease in the level of nitric oxide (р˂0,01). The data obtained indicate the role of dysfunction of the vascular endothelium in the pathogenesis of irritable bowel syndrome with constipation. An inverse correlation was found between the content of endothelin-1 and nitric oxide (p˂0.01), which indicates an increase in the activity of vasoconstrictor mechanisms with a simultaneous decrease in vasodilation factors. The effectiveness of complex therapy in the group of patients in whom folic acid and zincteral were used as part of complex therapy in improving the clinical picture of the disease (complete relief of dyspeptic syndrome and a significant decrease in the severity of pain, constipation and asthenic syndromes), restoration of vascular endothelial function (significant decrease in the level of endothelin-1 and an increase in the level of nitric oxide) in comparison with the group of patients in the treatment of which only basic therapy was used.
Downloads
References
Zvyagintseva TD, Gridneva SV. Novyye kontseptsii razvitiya sindroma razdrazhennogo kishechnika i podkhody k lecheniyu. Novosti meditsiny i farmatsii. (Gastroyenterologíya). 2016;(577):8-12 (In Russ.).
Zvyagintseva TD, Gridneva SV. Sindrom razdrazhennogo kishechnika: sovremennyye predstavleniya i novyye vozmozhnosti korrektsii. Skhídnoêvropeys'kiy zhurnal vnutríshn'oí̈ ta símeynoí̈ meditsini. 2018;(2):4-9 (In Russ.).
Fadeyenko GD, Gridnev AYe. Sindrom razdrazhennogo kishechnika i kishechnyy mikrobiom. Ot patogeneticheskikh mekhanizmov k lecheniyu. Novini meditsini ta farmatsíí̈. Zhurnal «Gastroenterologiya». 2018;52(4):8-9 (In Russ.).
Sheptulin AA, Vize-Khripunova MA. Novoye v etiologii i patogeneze sindroma razdrazhennogo kishechnika. Klinicheskaya meditsina. 2016; 94(2):92-96. (In Russ.). https://doi.org/10.18821/0023-2149-2016-94-2-92-96
Yankovskiy DS, Shirobokov VP, Dyment GS. Mikrobiom. 2017.640 р. (In Russ.). https://doi.org/10.11603/1681-2727.2018.3.9427
Cibor D, Domagala-Rodacka R et al. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol. 2016 Jan 21;22(3):1067–1077. https://doi.org/10.3748/wjg.v22.i3.1067
Frederik C. Enevoldsen, Jayashree Sahana et al. Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy. J Clin Med. 2020 Mar;9(3):824. https://doi.org/10.3390/jcm9030824
Houde M, Desbiens L, D'Orléans-Juste P. Endothelin-1: Biosynthesis, Signaling and Vasoreactivity. Adv. Pharmacol. 2016;77:143-75. https://doi.org/10.1016/bs.apha.2016.05.002
Lankhorst S, Danser AH et al. Endothelin-1 and antiangiogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016 Feb 01;310(3):230-4. https://doi.org/10.1152/ajpregu.00373.2015
Han W, Guo C et al. Role of endothelin and nitric oxide in the pathogenesis of irritable bowel syndrome. Chinese Journal of Gastroenterology. 2002; 7(6):342-344
Zhao Y, Vanhoutte PM. et al. Vascular nitric oxide: Beyond eNOS. J. Pharmacol. Sci. 2015 Oct;129(2):83-94. https://doi.org/10.1016/j.jphs.2015.09.002.
Muscara M, Wallace J. Therapeutic potential of nitric oxide donors and inhibitors. Am. Journal Physiol. 1999;276:G1313-1316 https://doi.org/10.1152/ajpgi.1999.276.6.G1313
Sal'nikova YeV. Potrebnost' cheloveka v tsinke i yego istochniki. Mikroelementy v meditsine. 2016;17(4):11-15 (In Russ.).
Liping Huang, Victoria J. Drake et al. Zinc. Advances in Nutrition. 2015;6 (2):224–226 https://doi.org/10.3945/an.114.006874
Takafumi Hara, Taka-aki Takeda et al. Physiological roles of zinc transporters: molecular and genetic importance in zinc homeostasis. The Journal of Physiological Sciences. 2017;(67):283–301 https://doi.org/10.1007/s12576-017-0521-4.
Sung Ryul Lee. Critical Role of Zinc as Either an Antioxidant or a Prooxidant in Cellular Systems. Oxidative medicine and cellular longevity. 2018;(15):1-11 https://doi.org/10.1155/2018/9156285
Sugimachi M, Kiyohara T, Murayama T. et al. Endogenous endothelin in a rat model of acute colonic mucosal injury. Gastroenterology and Hepatology. 2000;15(10):1125-1131 https://doi.org/10.1046/j.1440-1746.2000.02311.x